Apogee Therapeutics, Inc.
USD132.68
+0.07 (+0.05%)
CEO
Michael Thomas Henderson
IPO Date
2023-07-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$132.72
Prev. Close
$132.61
Day Low
$132.65
Day High
$132.83
52W Low
$34.34
52W High
$133.16
Market Cap
$8.19B
Volume
2.81M
| -13.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -22.1% | -20.9% | 0.01 | 19.38 | -16.9 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -28.0% | -26.2% | 0.00 | 15.24 | -27.0 |
| -16.5 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -11.1% | -10.4% | 0.02 | 15.86 | -9.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -10.7% | -10.0% | 0.02 | 16.36 | -9.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -8.2% | -7.7% | 0.02 | 15.82 | -9.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -9.4% | -8.9% | 0.02 | 18.55 | -9.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -6.7% | -6.3% | 0.02 | 16.39 | -17.0 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -4.4% | -4.2% | 0.01 | 27.70 | -16.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -4.0% | -3.9% | 0.00 | 38.08 | -25.4 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -8.4% | -7.9% | 0.01 | 19.38 | -11.1 |